Navigation Links
Fecal microbiota transplantation cures gastrointestinal diseases
Date:2/26/2013

(26 February 2013) Clostridium difficile infections have developed into a virtual pandemic over the past two decades. The outcome of standard antibiotic treatment is unsatisfactory: the recurrence rates are high with every relapse increasing the risk of further follow-ups. Faecal microbiota transplantation offers a rapidly acting and highly effective alternative in treating recurrent Clostridium difficile infections (RCDI), as Professor Lawrence J. Brandt (Montefiore Medical Center, New York, USA) points out. According to him, more than 90 per cent of the patients are being cured within a short period of time. Further information on this issue one of many topics presented at the 2nd World Summit "Gut Microbiota For Health" in Madrid, Spain, from 24 to 26 February 2013 can be found at http://bit.ly/SUN24PR.

To keep themselves up to date on the rapidly increasing advances in the field of gut microbiota research, scientists and health-care professionals came together at the 2nd Gut Microbiota For Health World Summit. This year, the event was hosted by the Gut Microbiota & Health Section of the European Society of Neurogastroenterology and Motility (ESNM) a member of United European Gastroenterology (UEG) and the American Gastroenterological Association (AGA), with the support of Danone Dairy.


'/>"/>

Contact: Aimee Frank
media@gastro.org
301-941-2620
American Gastroenterological Association
Source:Eurekalert

Page: 1

Related medicine news :

1. Caring for patients with fecal incontinence costs more than $4,000 per person each year
2. Groundbreaking clinical trial looks at fecal transplant as treatment for C. difficile
3. Fecal Transplant to Cure Gut Infection?
4. NIH team describes protective role of skin microbiota
5. Xenotransplantation as a therapy for type 1 diabetes
6. UCLA launches first face transplantation program in western US
7. Haematopoietic stem cell transplantation increases survival in systemic sclerosis patients
8. Antibodies from rabbits reduce risks associated with unrelated donor stem cell transplantation
9. Current and former smokers at risk for recurrent hepatitis post-liver transplantation
10. Special issue of Cell Transplantation features research presented at IANR
11. Wolters Kluwer Health and the Transplantation Society announce a partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/26/2016)... ... 2016 , ... PawPaws brand pet supplements owned by Whole Health ... the health of felines. The formula is all-natural and is made from Chinese herbs ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize each ... Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into hand ... select a ProHand generator and drag it above media or text in the Final ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of ... has announced the formation of a new biotechnology company, Noxopharm Limited ... $6m in an IPO and to list on the ASX. ... candidate, NOX66, ready to enter a Phase 1 clinical study later ... designed to address one of the biggest problems facing cancer patients ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: